NCT01613118 · Interventional trial
Randomized, Double-Blind, Safety and Efficacy Study of RE-021 (Sparsentan) in Focal Segmental Glomerulosclerosis
Overall registry status Completed
Phase 2
Conditions Focal Segmental Glomerulosclerosis
Delaware Valley sites
- Temple University School of Medicine · Philadelphia, PA · Philadelphia County
- The Children's Hospital of Philadelphia · Philadelphia, PA · Philadelphia County
- University of Pennsylvania, Perelman School of Medicine · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory